Aardvark Therapeutics, Inc. AARD 深 沪
交易中 05-18 10:44:09 美东时间
4.54
-0.030
-0.66%
华盛通- 最 高5.098
- 今 开4.49
- 成交量 6.57万股
- 最 低 4.49
- 昨 收 4.57
- 总市值 9904.64万
- 52周最高 17.94
- 市盈率 静 --
- 换手率 0.30%
- 52周最低 3.35
- 委 比 -8.79%
- 总股本 2181.64万
- 历史最高 19.58
- 量 比 1.56
- 振 幅 13.30%
- 历史最低 3.35
- 每 手 1
- 风险率 3.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 应用材料获17家大行集体上调目标价；Bitdeer 、Forgent 、嘉信理财、Viking等获多家大行上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从11美元升至12美元；Ladenburg Thalmann：维持Usio"买入"评级，目标价从5.75美元升至6.25美元
今天 11:48
BTIG Downgrades Aardvark Therapeutics to Neutral
BTIG analyst Jeet Mukherjee downgrades Aardvark Therapeutics (NASDAQ:AARD) from Buy to Neutral.
05-15 22:42
Aardvark Therapeutics Says FDA Places Full Clinical Hold On Its Investigational New Drug Application For ARD-101 Related To Prior Announced Voluntary Pause
Aardvark Therapeutics, Inc. (Aardvark or the Company) (NASDAQ:AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the
05-15 04:04
Aardvark Therapeutics Q1 EPS $(0.99) Misses $(0.90) Estimate
Aardvark Therapeutics (NASDAQ:AARD) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of $(0.90) by 10 percent. This is a 39.44 percent decrease over losses of $(0.71) per share
05-07 20:12
美股大行评级 | 潜在涨幅499.25%！Cabaletta Bio获Guggenheim升目标价至16美元，维持"买入"评级
今日重点评级关注：Guggenheim：维持Cabaletta Bio"买入"评级，目标价从15美元升至16美元；HC Wainwright & Co.：维持Palvella Therapeutics"买入"评级，目标价从255美元升至270美元
03-25 10:31
BTIG Reiterates Buy on Aardvark Therapeutics, Maintains $9 Price Target
BTIG analyst Jeet Mukherjee reiterates Aardvark Therapeutics (NASDAQ:AARD) with a Buy and maintains $9 price target.
03-24 18:59
Aardvark Therapeutics Q4 EPS $(0.81) Beats $(0.91) Estimate
Aardvark Therapeutics (NASDAQ:AARD) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(0.91) by 11.09 percent. This is a 62.5 percent increase over losses of $(2.16) per share
03-24 04:06
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular s...
03-21 01:06
What's Going On With Aardvark Therapeutics Stock On Wednesday?
Aardvark Therapeutics pauses Phase 3 HERO trial after cardiac safety observations, sending shares down nearly 61%.
03-04 21:54
